Expression of substance P receptor in the substantia nigra

Molecular Brain Research

Volumn 54, Issue 2, 1998, Pages 183-198

  Futami, T ^a,c   Hatanaka, Y ^a   Matsushita, K ^a   Furuya, S ^b  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b RIKEN   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Double labeling; Polyclonal antibody; Single cell RT PCR; SNc DA neurons; SP receptor mRNA; SP receptor protein; Tissue RT PCR

Indexed keywords

MESSENGER RNA; SUBSTANCE P RECEPTOR;

ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBSTANTIA NIGRA;

ANIMALS; ANTIBODY SPECIFICITY; COLCHICINE; DOPAMINE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NEURONS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RNA; SUBSTANTIA NIGRA; TRANSCRIPTION, GENETIC; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 0032031799     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00307-0     Document Type: Article

References (60)

1. Albin R.L., Reiner A., Anderson K.D., Penney J.B., Young A.B. Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol. 27:1990;357-365.
2. Anderson K.D., Karle E.J., Reiner A. Ultrastructural single- and double-label immunohistochemical studies of substance P-containing terminals and dopaminergic neurons in the substantia nigra in pigeons. J. Comp. Neurol. 309:1991;341-362.
3. 125I] Bolton-Hunter derivatives of eledoisin and substance P in the rat brain. Neurosci. 18:1986;857-875.
4. Bolam J.P., Smith Y. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat. Brain Res. 529:1990;57-78.
5. Brownstein M.J., Mroz E.A., Kizer J.S., Palkovits M., Leeman S.E. Regional distribution of substance P in the brain of the rat. Brain Res. 116:1976;299-305.
6. Brownstein M.J., Mroz E.A., Tappaz M.L., Leeman S.E. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra. Brain Res. 135:1977;315-323.
7. Buck S.H., Pruss R.M., Krstenansky J.L., Robinson P.J., Stauderman K.A. A tachykinin peptide receptor joins an elite club. Trends Pharmacol. Sci. 9:1988;3-5.
8. Burnette W.N. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radiolabeled protein A. Anal. Biochem. 112:1981;195-203.
9. S.B. Carroll, A. Laughon, Production and purification of polyclonal antibodies to the foreign segment of β-galactosidase fusion proteins, in: D.M. Glover (Ed.), DNA Cloning, Vol. 3, IRL Press, Oxford, 1987, pp. 89-111.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Danks J.A., Rothman R.B., Cascieri M.A., Chicchi G.G., Liang T., Herkenham M. A comparative autoradiographic study of the distributions of substance P and eledoisin binding sites in rat brain. Brain Res. 385:1986;273-281.
12. Dray A. The physiology and pharmacology of the mammalian basal ganglia. Prog. Neurobiol. 14:1980;221-335.
13. Elliott P.J., Iversen S.D. Behavioral effects of tachykinins and related peptides. Brain Res. 381:1986;68-76.
14. Emson P.C., Arregui A., Clement-Jones V., Sandberg B.E.B., Rossor M. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease. Brain Res. 199:1980;147-160.
15. 3H] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists. Eur. J. Pharmacol. 201:1991;231-234.
16. Fong T.M., Huang R.C., Strader C.D. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. J. Biol. Chem. 267:1992;25664-25667.
17. Furuya S., Irie F., Hashikawa T., Nakazawa K., Kozakai A., Hasegawa A., Sudo K., Hirabayashi Y. Ganglioside GD1a (alpha) in cerebellar Purkinje cells: its specific absence in mouse mutants with purkinje cell abnormality and altered immunoreactivity in response to conjunctive stimuli causing long-term desensitization. J. Biol. Chem. 269:1994;32418-32425.
18. Futami T., Richard C.D., Kitai S.T. Effects of substance P on spontaneous firing of dopamine (DA) neurons in the substantia nigra pars compacta (SNc). Soc. Neurosci. Abstr. 20:1994;564.
19. 2+ channels in substance P effects on spontaneous firing of dopamine (DA) neurons in the substantia nigra pars compacta (SNc). Eur. Neurosci. Abstr. 51:1995.
20. Futami T., Takakusaki K., Kitai S.T. Cholinergic projection from the pedunculopontine nucleus to dopamine neurons in the substantia nigra pars compacta. Neurosci. Res. 21:1995;331-342.
21. Gerfen C.R. Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556:1991;165-170.
22. Gray E.G., Whittaker V.P. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J. Anat. 96:1962;79-88.
23. Hall M.E., Stewart J.M. The substance P fragment SP(1-7) stimulates motor behavior and nigral dopamine release. Pharmacol. Biochem. Behav. 41:1992;75-78.
24. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391:1981;85-100.
25. Helke C.J., Krause J.E., Mantyh P.W., Couture R., Bannon M.J. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. FASEB J. 4:1990;1606-1615.
26. Herkenham M. Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neurosci. 23:1987;1-38.
27. Hershey A.D., Dykema P.E., Krause E. Organization, structure, and expression of the gene encoding the rat substance P receptor. J. Biol. Chem. 266:1991;4366-4374.
28. Hershey A.D., Krause J.E. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science. 247:1990;958-962.
29. Hong J.S., Yang H.T., Racagni G., Costa E. Projections of substance P containing neurons from neostriatum to substantia nigra. Brain Res. 122:1977;541-544.
30. Humpel C., Saria A., Regoli D. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism. Eur. J. Pharmacol. 195:1991;107-114.
31. James T.A., Starr M.S. Effects of substance P injected into the substantia nigra. Br. J. Pharmacol. 65:1979;423-429.
32. 2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron. 12:1994;1281-1289.
33. Kanazawa I., Jessell T. Post mortem changes and regional distribution of substance P in the rat and mouse nervous system. Brain Res. 117:1976;362-367.
34. Kanazawa I., Bird E.D., O'Connell R., Powell D. Evidence for a decrease in substance P content of substantia nigra in Huntington's chorea. Brain Res. 120:1977;387-392.
35. Keegan K.D., Woodruff G.N., Pinnock R.D. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro. Br. J. Pharmacol. 105:1992;3-5.
36. Kelley A.E., Iversen S.D. Behavioral response to bilateral injections of substance P into the substantia nigra of the rat. Brain Res. 158:1978;474-478.
37. 11] substance P, a new selective radioligand for the NK1 receptor. Eur. J. Pharmacol. 184:1990;97-108.
38. Maeno H., Kiyama H., Tohyama M. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. Brain Res. Mol. Brain Res. 18:1993;43-58.
39. Mantyh P.W. Correlation between inositol phospholipid hydrolysis and substance P receptors in rat CNS. Nature. 309:1984;795-797.
40. Mantyh P.W., Maggio J.E., Hunt S.P. The autoradiographic distribution of kassinin and substance K binding sites is different from the distribution of substance P binding sites in rat brain. Eur. J. Pharmacol. 102:1984;361-364.
41. Marksteiner J., Saria A., Krause J.E. Comparative distribution of neurokinin B-, substance P- and enkephalin-like immunoreactivities and neurokinin B mRNA in the basal forebrain of the rat: evidence for neurochemical compartmentation. Neurosci. 51:1992;107-120.
42. Mauborgne A., Javoy-Agid F., Legrand J.C., Agid Y., Cesselin F. Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Res. 268:1983;167-170.
43. Mendez I., Elisevich K., Flumerfelt B. Substance P synaptic interactions with GABAergic and dopaminergic neurons in rat substantia nigra. An ultrastructural double-labeling immunocytochemical study. Brain Res. Bull. 28:1992;557-563.
44. Merchenthaler I., Maderdrut J.L., O'Harte F., Conlon J.M. Localization of neurokinin B in the central nervous system of the rat. Peptides. 13:1992;815-829.
45. Nakaya Y., Kaneko T., Shigemoto R., Nakanishi S., Mizuno N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 347:1994;249-274.
46. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73:1993;229-308.
47. Overton P., Elliott P.J., Hagan M., Clark D. Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Eur. J. Pharmacol. 213:1992;165-166.
48. Pinnock R.D., Dray A. Differential sensitivity of presumed dopaminergic and non-dopaminergic neurones in the rat substantia nigra to electrophoretically applied substance P. Neurosci. Lett. 29:1982;153-158.
49. Quirion R., Shults C.W., Moody T.W., Pert C.B., Chase T.N., O'Donohue T.L. Autoradiographic distribution of substance P receptors in rat central nervous system. Nature. 303:1983;714-716.
50. Reid M.S., Herrera-Marschitz M., Kehr J., Ungerstedt U. Striatal dopamine and glutamate release: effects of intranigral injections of substance P. Acta Physiol. Scand. 140:1990;527-53733.
51. Saffroy M., Beaujouan J.C., Torrens Y., Besseyre J., Bergstrom L., Glowinski J. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides. 9:1988;227-241.
52. Santiago M., Machado A., Cano J. Fast sodium channel dependency of the somatodendritic release of dopamine in the rat's brain. Neurosci. Lett. 148:1992;145-147.
53. Shults C.W., Quirion R., Chronwal B., Chase T.N., O'Donohue T.L. A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system. Peptides. 5:1984;1097-1128.
54. Soloway M.R., Stjernschantz J., Sears M. The miotic effect of substance P on the isolated rabbit iris. Invest. Ophthalmol. Vis. Sci. 20:1981;47-52.
55. 11] substance P in rat brain and guinea pig ileum. Brain Res. 560:1991;1-11.
56. Towbin H., Staehlin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:1979;4350-4354.
57. Tsuchida K., Shigemoto R., Yokota Y., Nakanishi S. Tissue distribution and quantitation of the mRNAs for three rat tachykinin receptors. Eur. J. Biochem. 193:1990;751-757.
58. Waldmeier P.C., Kam R., Stocklin K. Increased dopamine metabolism in the rat striatum after infusion of substance P into the substantia nigra. Brain Res. 159:1978;223-227.
59. Walker R.J., Kemp J.A., Yajima H., Kitagawa K., Woodruff G.N. The action of substance P on mesencephalic reticular and substantia nigral neurones of the rat. Experientia. 32:1976;214-215.
60. Yokota Y., Sasai Y., Tanaka K., Fujiwara T., Tsuchida K., Shigemoto R., Kakizuka A., Ohkubo H., Nakanishi S. Molecular characterization of a functional cDNA for rat substance P receptor. J. Biol. Chem. 264:1989;17649-17652.